Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Homeostasis of Microglia in the Adult Brain: Review of Novel Microglia Depletion Systems.
The Elderly Person With Multiple Sclerosis: Clinical Implications for the Increasing Life-Span.
Estimating a Preference-Based Index for an Eight-Dimensional Health State Classification System for Multiple Sclerosis.
Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method.
Brain intra- and extracellular sodium concentration in multiple sclerosis: a 7 T MRI study.
Multiple sclerosis: potential risk factors in childhood and adolescence.
Does the preclinical evidence for functional remyelination following engraftment into the injured spinal cord support progression to clinical trials?
Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis.
Urodynamics in the Evaluation of the Patient with Multiple Sclerosis: When Are They Helpful and How Do We Use Them?
Cost-effectiveness of different interferon beta products for relapsing-remitting and secondary progressive multiple sclerosis: Decision analysis based on long-term clinical data and switchable treatments.
Enhancement of ventricular-subventricular zone-derived neurogenesis and oligodendrogenesis by erythropoietin and its derivatives.
Body mass index underestimates adiposity in persons with multiple sclerosis.
Assessment of the effect of cigarette smoking on regional brain volumes and lesion load in patients with clinically isolated syndrome.
The clinical features and diagnosis of Metachromatic leukodystrophy: A case series of Iranian Pediatric Patients.
Expression of Kir4.1 and Kir5.1 inwardly rectifying potassium channels in oligodendrocytes, the myelinating cells of the CNS.
Pharmacological treatment for memory disorder in multiple sclerosis.
Cerebrospinal fluid interleukin-6 in central nervous system inflammatory diseases.
Acute disseminated encephalomyelitis: an evaluation of 15 cases in childhood.
BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.
Do patient and proxy agree? Long-term changes in multiple sclerosis physical impact and walking ability on patient-reported outcome scales.
Optimizing the initial choice and timing of therapy in relapsing-remitting multiple sclerosis.
Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions.
Susceptibility Genes for Multiple Sclerosis Identified in a Gene-Based Genome-Wide Association Study.
Evaluation of the circulating CD34(+), CD309(+), and endothelial progenitor cells in patients with first attack of optic neuritis.
Pages
« first
‹ previous
…
657
658
659
660
661
662
663
664
665
…
next ›
last »